| [1] |
CHEN E, MULLALLY A. How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?[J]. Hematology Am Soc Hematol Educ Program, 2014, 2014(1): 268-276. DOI: 10.1182/asheducation-2014.1.268. |
| [2] |
TEFFERI A, GUGLIELMELLI P, LARSON DR, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis[J]. Blood, 2014, 124(16): 2507-2513; quiz 2615. DOI: 10.1182/blood-2014-05-579136. |
| [3] |
|
| [4] |
HARRISON CN, BAREFORD D, BUTT N, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis[J]. Br J Haematol, 2010, 149(3): 352-375. DOI: 10.1111/j.1365-2141.2010.08122.x. |
| [5] |
WEI C, ZHAO TC, ZHANG L, et al. A case of pseudo thrombocytosis caused by fragments of red blood cells[J]. Chin J Intern Med, 2020, 59(5): 380-381. DOI: 10.3760/cma.j.cn112138-20191203-00795. |
| [6] |
LARSEN PB, VIKESÅ J, FRⅡS-HANSEN L. EDTA-induced pseudothrombocytosis and citrate-induced platelet agglutination in a patient with Waldenstrom macroglobulinemia[J]. Clin Case Rep, 2017, 5(8): 1243-1247. DOI: 10.1002/ccr3.1035. |
| [7] |
JU MK, FU RF, LI HY, et al. Clinical characteristic of "triple-negative" essential thrombocythaemia patients and mutation analysis by targeted sequencing[J]. J Exp Hematol, 2018, 26(4): 1137-1145. DOI: 10.7534/j.issn.1009-2137.2018.04.032. |
| [8] |
JAMES C, UGO V, LE COUÉDIC JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera[J]. Nature, 2005, 434(7037): 1144-1148. DOI: 10.1038/nature03546. |
| [9] |
LEVINE RL, WADLEIGH M, COOLS J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis[J]. Cancer Cell, 2005, 7(4): 387-397. DOI: 10.1016/j.ccr.2005.03.023. |
| [10] |
VANNUCCHI AM, BARBUI T, CERVANTES F, et al. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2015, 26(Suppl 5): v85-v99. DOI: 10.1093/annonc/mdv203. |
| [11] |
LIU TT, QU XY, LIU AN, et al. Classical Hodgkin lymphoma with essential thrombocythemia: Report of one case and review of literature[J]. J Leukemia Lymphoma, 2017, 26(5): 294-296. DOI: 10.3760/cma.j.issn.1009-9921.2017.05.011. |
| [12] |
WEI ZL, HUANG LQ, WANG XH, et al. Coexistence of primary bone diffuse large B cell lymphoma complicated with primary thrombocythemia: A case report and literature review[J]. Chin J Pract Intern Med, 2016, 36(10): 915-918. DOI: 10.7504/nk2016090701. 韦中玲, 黄来全, 汪兴洪, 等. 原发性骨弥漫大B细胞淋巴瘤伴原发性血小板增多症1例报告并文献复习[J]. 中国实用内科杂志, 2016, 36(10): 915-918. DOI: 10.7504/nk2016090701. |
| [13] |
CHEN Z, WANG Y, HUANG B, et al. Essential thrombocythemia complicated with primary central nervous system lymphoma: A case report[J]. Chin J Hematol, 2009, 30(12): 803. DOI: 10.3760/cma.j.issn.0253-2727.2009.12.019. |
| [14] |
XIE YP, ZHANG JJ, HUANG XL, et al. Gastric mucosa associated lymphoma complicated with essential thrombocythemia: A case report[J]. J Clin Hematol, 2010, 23(1): 48. DOI: 10.3969/j.issn.1004-2806.2010.01.019. |
| [15] |
ESKAZAN AE, ONGOREN S, AR MC, et al. Essential thrombocythemia and multiple myeloma: Two rare diseases in one patient[J]. Clin Lymphoma Myeloma Leuk, 2011, 11(5): 442-445. DOI: 10.1016/j.clml.2011.04.001. |
| [16] |
HUANG J, LUO XH, ZHU Y, et al. Coexistence of multiple myeloma with essential thrombocythemia: A case report and literatures review[J]. Chin J Hematol, 2014, 35(8): 757-759. DOI: 10.3760/cma.j.issn.0253-2727.2014.08.022. |
| [17] |
KONDO H, SAKAI Y, TAKASO T. Coexistence of essential thrombocythemia and gastric cancer[J]. Rinsho Ketsueki, 1993, 34(2): 224-228.
|
| [18] |
|
| [19] |
|
| [20] |
LI SQ, QIN W, ZUO LH, et al. Hepatoblastoma in child with essential thrombocythemia: A case report[J]. Med & Pharm J Chin PLA, 2011, 23(4): 60. DOI: 10.3969/j.issn.2095-140X.2011.04.027. |
| [21] |
SEEGOBIN K, GHARIA B, MAHARAJ S, et al. Coexistent breast cancer and essential thrombocythemia: How we addressed the therapeutic challenges[J]. Case Rep Hematol, 2018, 2018: 2080185. DOI: 10.1155/2018/2080185. |
| [22] |
HIYOSHI M, NOZAWA H, INADA K, et al. Cecal cancer with essential thrombocythemia treated by laparoscopic ileocecal resection: A case report[J]. Surg Case Rep, 2019, 5(1): 101. DOI: 10.1186/s40792-019-0660-3. |
| [23] |
BRABRAND M, FREDERIKSEN H. Risks of solid and lymphoid malignancies in patients with myeloproliferative neoplasms: Clinical implications[J]. Cancers (Basel), 2020, 12(10): 3061. DOI: 10.3390/cancers12103061. |
| [24] |
MARCHETTI M, GHIRARDI A, MASCIULLI A, et al. Second cancers in MPN: Survival analysis from an international study[J]. Am J Hematol, 2020, 95(3): 295-301. DOI: 10.1002/ajh.25700. |
| [25] |
|
DownLoad:
